Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03764059 |
Other study ID # |
MDI0102 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
October 17, 2017 |
Est. completion date |
November 14, 2019 |
Study information
Verified date |
July 2023 |
Source |
3M |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Purpose of the Study:This study was to evaluate the 1 week, 1 year safety and effectiveness
of dental composite resin (Filtek™ Bulk Fill Posterior Restorative) in restoring Class I and
II dental cavities in posterior teeth.
Description:
This was a randomized, two- arm, non-inferiority study to evaluate the safety and clinical
performance of resin composite, Filtek™ Bulk Fill.
Test apparatus: Apparatus for Test: Filtek™ Bulk Fill Posterior Restorative Apparatus for
Control: 3M™ ESPE™ Filtek™ Z350XT, was approved by CFDA in 2010 and had been in the market
for 5 years with some validated clinical data.
Sample Size of Subjects: Two-hundred forty (240) patients were expected to be recruited into
the study and were randomly assigned to the test group and the control group according to the
ratio of 1: 1; thus the number of cases in each group was 120. Finally, a total of 240
subjects were randomly enrolled in the study, including 120 subjects in the test group and
120 subjects in the control group, which met the required sample size.
The study consisted of screening period (initial screening visit, post-preparation screening
visit), 1-week follow-up visit and 1-year follow-up visit, during which all the tests
required in the protocol would be conducted to select the subjects meeting the criteria for
inclusion. The examination and evaluation of the initial screening period were supposed to be
completed within 0.5 days. Then investigators would make an appointment with the subjects
eligible for the initial screening for cavity preparation and tooth filling, the required
time of which depended on the complexity of the tooth problem and would be completed within
0.5 days. Immediate evaluation of relevant indicators were offered to the subjects who were
selected and qualified after preparation and patients with qualified score would continue to
have the 1-week and 1-year follow-up visits.
Subjects were randomly assigned to either the test group (Filtek™ Bulk Fill Posterior
Repository) or the control group (Filtek™ Z350XT) in a central random manner, using the
corresponding test product or control product to fill and restore posterior teeth defects
(class I or class II cavities).
Since all investigators were required to operate according to instructions, it was clear to
them which product a subject was given. However, subjects and clinical evaluators were
blinded regarding whether the test product (Filtek™ Bulk Fill Posterior Repository) or the
control product (Filtek™ Z350XT) was used by the subjects.
Immediately after restoration placement, at 1 week and 1 year postoperative, two or three
clinical evaluators from each site performed the clinical assessment (the third more senior
evaluator performed the assessment and determination if the first two evaluators were not in
agreement) per China Technical Instruction and Guidance of Resin Composite Restoration
Material For CFDA Registration (Technical Instruction and Guidance in short). The clinical
acceptable rate of the restoration at 1 year was the primary endpoint in this study.
AE/SAE were collected to evaluate the safety of Filtek™ Bulk Fill. Based on the assessment
result, if the clinical acceptance rate of the two groups achieved the clinical acceptable
rate defined in the protocol, it indicated that Filtek™ Bulk Fill was efficacious for class 1
and II restorations.